Tag: Healthcare Industry

TPP’s biologics data protection

Article – BusinessDesk April 27 (BusinessDesk) – The Trans-Pacific Partnership’s longer data protection for biologic pharmaceutical makers will push up the cost of the fastest growing primary health treatment in the country, the Medical Association says.TPP’s biologics data protection will push up health-care costs, Medical Association says By Paul McBeth April 27 (BusinessDesk) – The Trans-Pacific Partnership’s longer data protection for biologic pharmaceutical makers will push up the cost of the fastest growing primary health treatment in the country, the Medical Association says. Biologic drugs account for more than 40 percent of new pharmaceutical products being developed and proposals...

Read More

Government returning to failed market approach to health

Press Release – ASMS The Government appears to be sidling back to a market-drive approach to the provision of public hospital services, says Ian Powell, Executive Director of the Association of Salaried Medical Specialists (ASMS).Government stealthily returning to failed market approach to health “The Government appears to be sidling back to a market-drive approach to the provision of public hospital services,” says Ian Powell, Executive Director of the Association of Salaried Medical Specialists (ASMS). “It’s all happening in the background and largely below the radar, which is of concern, and it really warrants active scrutiny,” he says. “For example, when we look at the Ministry of Health executive restructure announced recently, we note that the functions of the apparently disbanded National Health Board appear to be reduced but there is an increased emphasis on market mechanisms such as tendering through commissioning, and the language of the market – clients and customers.” Details of the Ministry of Health restructure are available at http://www.health.govt.nz/news-media/news-items/ministry-health-executive-leadership-structure-announced. Mr Powell says there are also signs of a return to the failed market health experiments of the 1990s in the updated draft New Zealand Health Strategy. “The Government’s health funding review, whose controversial recommendations were leaked to the media last year, underpins the draft updated health strategy. This strategy document clearly points to a competitive market model of health service provision and opens the doors to...

Read More

TPP: Ambiguous provision for medicines a major worry for NZ

Press Release – Doctors for Healthy Trade The delayed publication of the final TPP text on Thursday has raised concerns amongst health experts that the victory Australia and New Zealand have claimed over the US demand to extend monopolies on biologic medicines could be undermined by ambiguities …TPP: Ambiguous provision regarding biologic medicines a major worry for NZ The delayed publication of the final TPP text on Thursday has raised concerns amongst health experts that the victory Australia and New Zealand have claimed over the US demand to extend monopolies on biologic medicines could be undermined by ambiguities in the text. “The actual legal terms of the TPP are what will matter in any dispute that arises, rather than the understandings the trade ministers feel they reached in Atlanta” said Dr Deborah Gleeson, a public health researcher from Australia’s La Trobe University who has been following the TPP negotiations for over four years and has published extensively on the TPP and access to medicines. “The text offers two options: at least eight years of protection of clinical trial data; or at least five years of data protection along with other measures to deliver a comparable outcome in the market” said Dr Gleeson. “This leaves room for the US to continue to pressure countries to use administrative delays to keep affordable medicines off the market for an equivalent period of...

Read More

Power of balance poised to tip even further

Press Release – ASMS International reports suggest that the latest proposal under the Trans Pacific Partnership Agreement (TPPA) would effectively mean an extra three years of monopolies for biologic medicines, says Ian Powell, Executive Director of the Association of Salaried Medical …Power of balance poised to tip even further in favour of drug companies International reports suggest that the latest proposal under the Trans Pacific Partnership Agreement (TPPA) would effectively mean an extra three years of monopolies for biologic medicines, says Ian Powell, Executive Director of the Association of Salaried Medical Specialists (ASMS). “If correct, this is yet another concerning aspect of the TPPA negotiations and just one more reason why the terms of this trade deal need to be more transparent,” he says. The organisation Public Citizen says a tweaked approach to the impasse over biologics, which are medical products derived from living organisations, is apparently being explored by some TPPA negotiators – but it warns that this approach is flawed: http://www.citizen.org/documents/new-tpp-maneuvering-on-biotetch-drugs-september-2015.pdf It says the United States trade representative has sought minimum eight-year exclusivity periods for biologics, three years more than the current exclusivity periods in many TPPA countries, including New Zealand. “Extending pharmaceutical monopoly over medicines used by New Zealanders just further tips the balance of power away from patients, and it needs to be rejected,” says Mr Powell. Auckland clinical microbiologist and ASMS member Joshua Freeman,...

Read More

Doctors concerned at lack of information on TPPA

Press Release – Doctors for Healthy Trade Doctors are calling upon the government to provide more information about the secretive Trans-Pacific Partnership Agreement (TPPA) in response to claims by the Prime Minister that last weekends protesters were misinformed. Doctors, other health professionals, …Doctors concerned at lack of information on TPPA Doctors are calling upon the government to provide more information about the secretive Trans-Pacific Partnership Agreement (TPPA) in response to claims by the Prime Minister that last weekend’s protesters were “misinformed”. Doctors, other health professionals, and their families braved the weather and turned out across the country to express their deep concern at the TPPA. “Our concern over TPPA secrecy is valid. If we are misinformed, then give us full and accurate information” said Dr Erik Monasterio, a Christchurch psychiatrist, speaking for Doctors for Healthy Trade. “Despite the protests of the Trade Minister, there is no good reason for his secrecy over the TPPA. There are very good reasons for more openness. The European equivalent of the TPPA, the Trans Atlanctic Trade and Investment Partnership (the TTIP) is widely available and debated after the European Union Ombudsman ordered the release of parts of the negotiation documents citing strong public interest and rights to know” Dr Monasterio added. Medical concern about the TPPA is very widespread. Supporters of Doctors for Healthy Trade work in all medical specialities right across New...

Read More